Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
83.81
-2.93 (-3.38%)
At close: Apr 28, 2026, 4:00 PM EDT
83.55
-0.26 (-0.31%)
After-hours: Apr 28, 2026, 7:58 PM EDT
Nektar Therapeutics Market Cap
Nektar Therapeutics has a market cap or net worth of $2.83 billion as of April 28, 2026. Its market cap has increased by 2,359.07% in one year.
Market Cap
2.83B
Enterprise Value
2.73B
1-Year Change
2,359.07%
Ranking
Category
Stock Price
$83.81
Market Cap Chart
Since December 1, 1998, Nektar Therapeutics's market cap has increased from $478.60M to $2.83B, an increase of 490.88%. That is a compound annual growth rate of 6.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 2.40B | 179.57% |
| Dec 31, 2025 | 860.00M | 401.46% |
| Dec 31, 2024 | 171.50M | 59.09% |
| Dec 29, 2023 | 107.80M | -74.62% |
| Dec 30, 2022 | 424.80M | -82.96% |
| Dec 31, 2021 | 2.49B | -18.24% |
| Dec 31, 2020 | 3.05B | -19.69% |
| Dec 31, 2019 | 3.80B | -33.26% |
| Dec 31, 2018 | 5.69B | -39.50% |
| Dec 29, 2017 | 9.40B | 401.47% |
| Dec 30, 2016 | 1.88B | -16.61% |
| Dec 31, 2015 | 2.25B | 12.95% |
| Dec 31, 2014 | 1.99B | 51.06% |
| Dec 31, 2013 | 1.32B | 54.43% |
| Dec 31, 2012 | 853.40M | 33.30% |
| Dec 30, 2011 | 640.20M | -47.19% |
| Dec 31, 2010 | 1.21B | 39.56% |
| Dec 31, 2009 | 868.60M | 68.99% |
| Dec 31, 2008 | 514.00M | -16.91% |
| Dec 31, 2007 | 618.60M | -54.96% |
| Dec 29, 2006 | 1.37B | -4.78% |
| Dec 30, 2005 | 1.44B | -15.13% |
| Dec 31, 2004 | 1.70B | 122.51% |
| Dec 31, 2003 | 763.80M | 70.57% |
| Dec 31, 2002 | 447.80M | -56.04% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beam Therapeutics | 3.06B |
| Alumis | 3.06B |
| Dyne Therapeutics | 3.00B |
| Kailera Therapeutics | 2.93B |
| Arcutis Biotherapeutics | 2.92B |
| Kodiak Sciences | 2.80B |
| Soleno Therapeutics | 2.73B |
| Immunome | 2.68B |